Biosimilars: More Treatment Options Are on the Way

The Food and Drug Administration (FDA) is approving Zarxio (filgrastim-sndz), the first biosimilar product (or biosimilar), and expects to approve others in the months ahead. What are biosimilars? How will they affect patient treatment?
Source: FDA Consumer Updates - Category: Consumer Health News Source Type: news